Pruritus burden assessment in severe atopic dermatitis patients under dupilumab: response predictor?

Eur Ann Allergy Clin Immunol. 2023 Jul 28. doi: 10.23822/EurAnnACI.1764-1489.308. Online ahead of print.

Authors

R Brás¹, R Limão¹, E Pedro¹, A Lopes^{1

2}

Affiliations

¹ Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
² Universitary Clinic of Immunoallergology, Faculty of Medicine, Universidade de Lisboa, Lisbon, Portugal.

PMID: 37503751
DOI: 10.23822/EurAnnACI.1764-1489.308

No abstract available

Keywords: Anti-IL-4/IL-13; atopic dermatitis; dupilumab; pruritus.

Publication types

Letter